Eurasian Journal of Medicine and Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.3 | Q2 | 52.7% | 0.238 | Q3 | 34.9% |
| 2024 | 0.7 | Q3 | 39.0% | 0.195 | Q3 | 29.9% |
| 2023 | 0.8 | Q4 | 10.3% | 0.254 | Q3 | 43.5% |
| 2022 | 2.5 | 32.8% | 0.208 | Q3 | 38.8% | |
| 2021 | — | 25.2% | — | 7.1% | ||
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2587-2400
ISSN
2587-196X
country
coverage
2019-2025